Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Quantitative Analysis

<ul>
<li>We analyzed the latest HK SFC report for aggregate short position as of Feb 11. </li>
<li>Top short increases and decreases were tabulated for one week and four week period. </li>
<li>We highlight short interest changes in Bank of China, Wuxi Biologics, and Wuxi Apptec.</li>
</ul>


We analyzed the latest HK SFC report for aggregate short position as of Feb 11. 
Top short increases and decreases were tabulated for one week and four week period. 
We highlight short interest changes in Bank of China, Wuxi Biologics, and Wuxi Apptec.


HK Short Interest: BOC, Wuxi Biologics/Apptec

Fintech & EM-focused Analyst, KT Capital Group

Alec Tseung

Fintech & EM-focused Analyst

KT Capital Group

Principal investments and advisory firm that focuses on connecting the CIS countries with East Asia.

Principal investments and advisory firm

Equity Bottom-Up

<ul>
<li>Huize's further acceleration of the "online to offline integration strategy" likely pushes it to compete more directly against China's insurance giants (e.g., Ping An).</li>
<li>One key challenge smaller Chinese insurtech players face (when it comes to attracting investors) is that some of the country's insurance giants are relatively well digitized.</li>
<li>Ping An still represents a good way to gain exposure to China's broader insurance/insurtech space, especially given its current low valuation. </li>
</ul>


Huize's further acceleration of the "online to offline integration strategy" likely pushes it to compete more directly against China's insurance giants (e.g., Ping An).
One key challenge smaller Chinese insurtech players face (when it comes to attracting investors) is that some of the country's insurance giants are relatively well digitized.
Ping An still represents a good way to gain exposure to China's broader insurance/insurtech space, especially given its current low valuation. 


Huize: Getting More Difficult to Justify an Investment

Asset Allocation & Fund Positioning, Copley Fund Research

Steven Holden

Asset Allocation & Fund Positioning

Copley Fund Research

Copley Fund Research provide research and data on asset allocation among Global and Emerging Market equity funds.  The analysis details absolute and relative positioning across countries, sectors and industries together with highly granular data on single stock and single fund allocations.  The data is updated monthly with time series going back to January 2011.

Global Research - Analysis of 165 prominent Global equity funds, combined AUM $335bn
GEM Research - Analysis of 127 prominent global EM equity funds, combined AUM $250bn

Asset Allocation - Global and GEM Equity

<ul>
<li>PT Bank Central Asia has ownership among GEM active funds has hit record highs.</li>
<li>Aggressive Growth managers account for 14 of the largest 20 positions in the stock, led by Virtus EM Growth (4.16%) and Mirae EM Great Consumer (4.07%).</li>
<li>It is the 12th most widely held stock globally and the 4th most widely held stock in the Financials sector.  Competition lies in Sberbank, CCB and Ping An Insurance.</li>
</ul>


PT Bank Central Asia has ownership among GEM active funds has hit record highs.
Aggressive Growth managers account for 14 of the largest 20 positions in the stock, led by Virtus EM Growth (4.16%) and Mirae EM Great Consumer (4.07%).
It is the 12th most widely held stock globally and the 4th most widely held stock in the Financials sector.  Competition lies in Sberbank, CCB and Ping An Insurance.


Bank Central Asia: GEM Funds Hit Max Exposure

Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of Research, IPOs & Placements

Equity Capital Markets

Life Insurance  of India / Equity Capital Markets

<ul>
<li>The Government of India (GoI) is looking to raise around US$5-10bn via selling a 5% stake in Life Insurance Corporation of India (LIC) in its upcoming India IPO.</li>
<li>The deal will be run by Kotak, Axis, BofA, Citi, Nomura, GS, ISec, JM Fin, JPM, SBI Caps.</li>
<li>This note provides a brief overview of the company and the deal.</li>
</ul>


The Government of India (GoI) is looking to raise around US$5-10bn via selling a 5% stake in Life Insurance Corporation of India (LIC) in its upcoming India IPO.
The deal will be run by Kotak, Axis, BofA, Citi, Nomura, GS, ISec, JM Fin, JPM, SBI Caps.
This note provides a brief overview of the company and the deal.


Life Insurance Corporation of India IPO Tearsheet

<ul>
<li>We analyzed the latest HK SFC report for aggregate short position as of Feb 4th.</li>
<li>Top short increases and decreases were tabulated for one week and four week period. </li>
<li>We highlight short interest increases in HKEx and Country Garden in the past four weeks. </li>
</ul>


We analyzed the latest HK SFC report for aggregate short position as of Feb 4th.
Top short increases and decreases were tabulated for one week and four week period. 
We highlight short interest increases in HKEx and Country Garden in the past four weeks. 


China

Ping An Insurance (Group) Company of China Limited provides products and services through its five ecosystems in financial services, healthcare, auto services, real estate services and Smart City solutions. The Group's insurance business writes property, casualty, and life insurance products.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Ping An Insurance Group of (601318 CH)

HK Short Interest: BOC, Wuxi Biologics/Apptec

We highlight week on week short interest changes in Bank of China, Wuxi Biologics, and Wuxi Apptec based on the latest Hong Kong SFC short...

Ke Yan, CFA, FRM

Huize: Getting More Difficult to Justify an Investment

Ping An's low valuation has made it difficult to justify an investment in Huize and other smaller insurtech players in China.

Alec Tseung

Bank Central Asia: GEM Funds Hit Max Exposure

Ownership in PT Bank Central Asia has hit record highs. Of the 246 active GEM funds in our analysis, 46.3% own BBCA and 40.24% are overweight the...

Steven Holden

Life Insurance Corporation of India IPO Tearsheet

The Government of India (GoI) is looking to raise around US$5-10bn via selling a 5% stake in Life Insurance Corporation of India (LIC) in its...

Sumeet Singh

HK Short Interest: HKEx, Country Garden

We highlight short interest increases in HKEx (388 HK) and Country Garden (2007 HK) in the past four weeks based on the latest short aggregate...

Ke Yan, CFA, FRM

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)